BIO International 2025

🇺🇸 🇫🇷 Lys Therapeutics is excited to join the #BIO International Convention 2025 in #Boston, from June 16–19, as part of the French Pavilion, organized by Business France and its partners.

Our team, represented by Dr. Manuel Blanc (CEO & Co-founder) and Philippe Dujardin (CFO & Co-founder), will be available for BIO One-on-One Partnering™ meetings to present our innovative monoclonal antibody #LYS241, a pipeline-in-a-drug program developed to address major unmet needs in neurological diseases including #Stroke, #MultipleSclerosis, and #Parkinson’s disease.

We are looking forward to discussing our first-in-class programs targeting #neuroinflammation, #excitotoxicity, and blood-brain barrier dysfunction with fellow innovators in the neurology space.

📍 Meet us in Boston — June 16–19, 2025

🤝 Schedule a partnering meeting via the BIO platform [no service providers]

With Business France North America, Business France Healthcare – North America, Business France, French Healthcare, LyonbiopĂ´le Auvergne-RhĂ´ne-Alpes, Agence de l’innovation en santĂ©.

#BIO2025 #Partnering #Biotech #Neuroscience #Neuroinflammation #CNS #Stroke #MS #Parkinson #LYS241 #LysTherapeutics #ChooseFrance #Innovation #FrenchPavilion